Category Archives: Top News

Gilead Sciences Receives a Hold from Maxim Group

479712.png

Maxim Group analyst Gabrielle Zhou reiterated a Hold rating on Gilead Sciences (NASDAQ: GILD) today. The company’s shares opened today at $66.54. Zhou wrote: “Gilead announced positive data for GS-0976 at the 53rd Annual Meeting of the European Association for

Analysts Offer Insights on Technology Companies: Facebook Inc (NASDAQ: FB) and Qualcomm Inc (NASDAQ: QCOM)

479490.png

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Facebook Inc (NASDAQ: FB) and Qualcomm Inc (NASDAQ: QCOM) with bullish sentiments. Facebook Inc (NASDAQ: FB) Oppenheimer analyst Jason Helfstein reiterated a

Pacific Crest Releases a Buy Rating on Microsoft Corp

479444.jpg

In a report released yesterday, Brent Bracelin from Pacific Crest reiterated a Buy rating on Microsoft Corp (NASDAQ: MSFT), with a price target of $70. The company’s shares closed yesterday at $65.04. Bracelin observed: “We expect another solid earnings report

Yahoo! Receives a Buy from Oppenheimer

479360.gif

Oppenheimer analyst Jason Helfstein reiterated a Buy rating on Yahoo! (NASDAQ: YHOO) today and set a price target of $57. The company’s shares closed yesterday at $47.56. Helfstein observed: “Yahoo reported 1Q:17 earnings after the close, noting “the company anticipates

Agios Pharma Receives a Buy from Oppenheimer

479286.jpg

In a report released yesterday, Leah R. Cann from Oppenheimer reiterated a Buy rating on Agios Pharma (NASDAQ: AGIO), with a price target of $75. The company’s shares closed yesterday at $50.36. R. Cann commented: “Agios Pharmaceuticals announced today that

Petroleo Brasileiro SA- Petrobras Gets a Buy from Credit Suisse

479262.png

Credit Suisse analyst Andre Natal reiterated a Buy rating on Petroleo Brasileiro SA- Petrobras (NYSE: PBR) yesterday and set a price target of $11. The company’s shares opened today at $9.36. Natal noted: “We remind investors that the total deal